DK1512015T3 - Fremgangsmåder til forbedring af bindingsegenskaber hos et molekyle - Google Patents
Fremgangsmåder til forbedring af bindingsegenskaber hos et molekyleInfo
- Publication number
- DK1512015T3 DK1512015T3 DK03760249T DK03760249T DK1512015T3 DK 1512015 T3 DK1512015 T3 DK 1512015T3 DK 03760249 T DK03760249 T DK 03760249T DK 03760249 T DK03760249 T DK 03760249T DK 1512015 T3 DK1512015 T3 DK 1512015T3
- Authority
- DK
- Denmark
- Prior art keywords
- molecule
- methods
- improving
- binding properties
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38838602P | 2002-06-12 | 2002-06-12 | |
PCT/US2003/018187 WO2003107009A2 (en) | 2002-06-12 | 2003-06-09 | Methods for improving a binding characteristic of a molecule |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1512015T3 true DK1512015T3 (da) | 2009-07-06 |
Family
ID=29736463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03760249T DK1512015T3 (da) | 2002-06-12 | 2003-06-09 | Fremgangsmåder til forbedring af bindingsegenskaber hos et molekyle |
Country Status (8)
Country | Link |
---|---|
US (2) | US20060088838A1 (de) |
EP (2) | EP2107116A3 (de) |
AT (1) | ATE426815T1 (de) |
AU (1) | AU2003248652A1 (de) |
CA (1) | CA2489022C (de) |
DE (1) | DE60326839D1 (de) |
DK (1) | DK1512015T3 (de) |
WO (1) | WO2003107009A2 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1942203A (zh) * | 2004-06-04 | 2007-04-04 | 金克克国际有限公司 | 使用抗体重链的筛选方法 |
WO2006116076A2 (en) | 2005-04-28 | 2006-11-02 | Genencor International, Inc. | Tab molecules |
EP4238993A3 (de) | 2008-04-11 | 2023-11-29 | Chugai Seiyaku Kabushiki Kaisha | Antigenbindendes molekül zur wiederholten bindung an zwei oder mehr antigenmoleküle |
TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
SG190727A1 (en) | 2010-11-30 | 2013-07-31 | Chugai Pharmaceutical Co Ltd | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
KR102147548B1 (ko) | 2011-02-25 | 2020-08-24 | 추가이 세이야쿠 가부시키가이샤 | FcγRIIb 특이적 Fc 항체 |
TW201817745A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
JP6322411B2 (ja) | 2011-09-30 | 2018-05-09 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
EP3517550A1 (de) | 2011-11-30 | 2019-07-31 | Chugai Seiyaku Kabushiki Kaisha | Arzneimittelhaltiger träger in zellen zur bildung eines immunkomplexes |
LT2825036T (lt) | 2012-03-16 | 2018-07-10 | Regeneron Pharmaceuticals, Inc. | Histidino pakeitimus lengvoje grandinėje turintys antikūnai ir genetiškai modifikuoti graužikai, išvesti ju gamybai |
RS59076B1 (sr) | 2012-03-16 | 2019-09-30 | Regeneron Pharma | Glodari koji eksprimiraju imunoglobulinske sekvence senzitivne na ph |
TWI808330B (zh) | 2014-12-19 | 2023-07-11 | 日商中外製藥股份有限公司 | 抗肌抑素之抗體、含變異Fc區域之多胜肽及使用方法 |
SG11201607165YA (en) | 2014-12-19 | 2016-09-29 | Chugai Pharmaceutical Co Ltd | Anti-c5 antibodies and methods of use |
TW202248212A (zh) | 2015-02-05 | 2022-12-16 | 日商中外製藥股份有限公司 | 包含離子濃度依賴之抗原結合域的抗體、Fc區變體、IL-8結合抗體與其用途 |
TW202339800A (zh) | 2015-02-27 | 2023-10-16 | 日商中外製藥股份有限公司 | Il-6受體抗體用於製備醫藥組成物的用途 |
EP3394098A4 (de) | 2015-12-25 | 2019-11-13 | Chugai Seiyaku Kabushiki Kaisha | Anti-myostatin-antikörper und verfahren zur verwendung |
EP3494991A4 (de) | 2016-08-05 | 2020-07-29 | Chugai Seiyaku Kabushiki Kaisha | Zusammensetzung zur vorbeugung oder behandlung von erkrankungen im zusammenhang mit il-8 |
JP7191833B2 (ja) | 2017-01-30 | 2022-12-19 | 中外製薬株式会社 | 抗スクレロスチン抗体およびその使用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2207301A (en) | 1937-05-15 | 1940-07-09 | Nat Electric Prod Corp | Underfloor duct |
US2209701A (en) | 1938-03-08 | 1940-07-30 | Andrew J Mcgann | Device for cutting or scoring necks of bottles |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US5200313A (en) * | 1983-08-05 | 1993-04-06 | Miles Inc. | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies |
US4711845A (en) | 1984-08-31 | 1987-12-08 | Cetus Corporation | Portable temperature-sensitive control cassette |
US4666848A (en) | 1984-08-31 | 1987-05-19 | Cetus Corporation | Polypeptide expression using a portable temperature sensitive control cassette with a positive retroregulatory element |
EP0196864A3 (de) | 1985-03-25 | 1988-03-23 | Cetus Corporation | Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen |
US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5965132A (en) | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
EP2369007B1 (de) * | 1996-05-29 | 2015-07-29 | Cornell Research Foundation, Inc. | Erkennung von Nukleinsäuresequenz-Unterschieden mittels der gleichzeitigen Ligaseerkennungs- und Polymerasekettenreaktion |
JP3935509B2 (ja) * | 1997-02-12 | 2007-06-27 | ワイ. チャン,ユージーン | ポリマー分析のための方法および製品 |
AU2002351193A1 (en) * | 2001-11-28 | 2003-06-10 | Mj Bioworks Incorporated | Parallel polymorphism scoring by amplification and error correction |
WO2004031408A1 (en) * | 2002-09-30 | 2004-04-15 | F.Hoffmann-La Roche Ag | Oligonucleotides for genotyping thymidylate synthase gene |
US7354706B2 (en) * | 2003-09-09 | 2008-04-08 | The Regents Of The University Of Colorado, A Body Corporate | Use of photopolymerization for amplification and detection of a molecular recognition event |
WO2005047521A2 (en) * | 2003-11-10 | 2005-05-26 | Investigen, Inc. | Methods of preparing nucleic acid for detection |
-
2003
- 2003-06-09 CA CA2489022A patent/CA2489022C/en not_active Expired - Fee Related
- 2003-06-09 DK DK03760249T patent/DK1512015T3/da active
- 2003-06-09 DE DE60326839T patent/DE60326839D1/de not_active Expired - Lifetime
- 2003-06-09 EP EP09001498A patent/EP2107116A3/de not_active Withdrawn
- 2003-06-09 AT AT03760249T patent/ATE426815T1/de not_active IP Right Cessation
- 2003-06-09 AU AU2003248652A patent/AU2003248652A1/en not_active Abandoned
- 2003-06-09 WO PCT/US2003/018187 patent/WO2003107009A2/en not_active Application Discontinuation
- 2003-06-09 EP EP03760249A patent/EP1512015B1/de not_active Expired - Lifetime
- 2003-06-09 US US10/514,446 patent/US20060088838A1/en not_active Abandoned
-
2007
- 2007-12-18 US US11/958,592 patent/US20080146456A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1512015B1 (de) | 2009-03-25 |
WO2003107009A3 (en) | 2004-04-15 |
DE60326839D1 (de) | 2009-05-07 |
US20060088838A1 (en) | 2006-04-27 |
US20080146456A1 (en) | 2008-06-19 |
CA2489022A1 (en) | 2003-12-24 |
EP2107116A3 (de) | 2009-12-09 |
AU2003248652A1 (en) | 2003-12-31 |
CA2489022C (en) | 2012-10-16 |
EP2107116A2 (de) | 2009-10-07 |
WO2003107009A2 (en) | 2003-12-24 |
EP1512015A2 (de) | 2005-03-09 |
ATE426815T1 (de) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1512015T3 (da) | Fremgangsmåder til forbedring af bindingsegenskaber hos et molekyle | |
WO2007130453A3 (en) | Non-natural amino acid substituted polypeptides | |
WO2009026393A3 (en) | Amino acid substituted molecules | |
DE602004025101D1 (de) | Humane anti-humane cd3-bindungsmoleküle | |
WO2006124737A3 (en) | Molecular constructs suitable for targeted conjugates | |
RS51847B (en) | BINDING MOLECULES WHICH MAY NEUTRALIZE FRAGILE VIRUS AND USE | |
ATE555202T1 (de) | Verfahren zur lieferung von rna-interferenz und verwendungen damit | |
EA200601670A1 (ru) | Конъюгаты гидроксиалкилкрахмала и белка | |
ATE446972T1 (de) | Il-1 bindende antikörper und fragmente davon | |
EA200702347A1 (ru) | Способ получения глюкопиранозилзамещённых производных бензилбензола и промежуточных продуктов для их получения | |
DE60336867D1 (de) | Verfahren zur Herstellung von 3-Halo-4,5-Dihydro-1H-Pyrazolen | |
DK1963361T3 (da) | Multimere komplekser af antigener og c4bp | |
DE60313659D1 (de) | Borrelidin-derivate und ihre medizinische anwendung | |
CY1110185T1 (el) | Τροποποιημενη πρωτεϊνη vp1-καψιδιου του παρβοϊου β19 | |
BRPI0615272A2 (pt) | inibidores de p38 map kinase e métodos para uso dos mesmos | |
CY1109631T1 (el) | Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ | |
EA200800785A1 (ru) | 4-арил-1,4-дигидро-3(2н)-изохинолиноны и 4-арил-1,2,3,4-тетрагидроизохинолины в качестве ингибиторов igf-1r и в качестве фармакологического средства в тест-системах, фармацевтическая композиция и изделие на их основе и способ лечения заболеваний, опосредованных igf-1 рецептором | |
NO20021686D0 (no) | Fremgangsmåter for fremstilling av målemolekyler i et transgent dyr og rensing av målmolekylet | |
WO2006079057A3 (en) | Methods and compositions for specific inhibition of protein splicing by small molecules | |
EA200701852A1 (ru) | Производные аминокислот | |
WO2009001203A3 (en) | An improved process for the preparation of aprepitant | |
NO20082989L (no) | Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet | |
EA200701578A1 (ru) | Способ конъюгирования молекул, содержащих аминотиол, к носителям | |
NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
DE50212728D1 (de) | Verfahren zur herstellung von 2-azetidinonderivaten |